Using Multiple Drug Exposure Levels to Optimize Power in Pharmacogenetic Trials

  • Richard Judson
  • The Journal of Clinical Pharmacology, August 2003, Wiley
  • DOI: 10.1177/0091270003254801

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1177/0091270003254801

The following have contributed to this page: Dr Richard S Judson

In partnership with:

Link to Wiley showcase

join the fight against climate change

Our simple summaries of climate research help you take action

Read now

climate-change.info